MedPacto, Inc. (KOSDAQ:235980)
South Korea · Delayed Price · Currency is KRW 5,790.00
+490.00 (9.25%)
Mar 20, 2026, 3:30 PM KST
MedPacto Market Cap
MedPacto has a market cap or net worth of 198.45 billion as of March 20, 2026. Its market cap has increased by 68.80% in one year.
Market Cap
198.45B
Enterprise Value
156.91B
Revenue
2.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,790.00
Market Cap Chart
Since December 19, 2019, MedPacto's market cap has decreased from 362.50B to 198.45B, a decrease of -45.25%. That is a compound annual growth rate of -9.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 198.45B | -13.32% |
| Dec 30, 2025 | 228.96B | 50.62% |
| Dec 30, 2024 | 152.01B | -37.48% |
| Dec 28, 2023 | 243.12B | -48.17% |
| Dec 29, 2022 | 469.05B | -60.97% |
| Dec 30, 2021 | 1.20T | -49.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JETEMA, | 319.76B |
| Bioneer | 313.34B |
| HLB Therapeutics | 275.93B |
| Helixmith | 260.63B |
| EASY BIO,Inc. | 229.92B |
| Genexine | 216.71B |
| Vaxcell-Bio Therapeutics | 190.01B |
| Macrogen | 178.02B |